Competence Network for Congenital Heart Defects
10
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.0%
2 terminated/withdrawn out of 10 trials
77.8%
-8.7% vs industry average
30%
3 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Efficacy of a Web-Based Emotion Regulation Intervention for Patients With Congenital Heart Disease
Role: collaborator
Myocarditis Registry for Children and Adolescents - MYKKE
Role: collaborator
Cardiac Resynchronization Therapy in Congenital Heart Defects
Role: lead
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
Role: lead
Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot
Role: lead
Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot
Role: lead
Follow up of Post-repair Tetralogy of Fallot
Role: lead
Right Ventricular Failure in Congenital Heart Defects
Role: lead
Pulmonary Arteriopathy-Diagnostics and Therapy
Role: lead
Bosentan in Treatment of Pulmonary Arterial Hypertension
Role: lead
All 10 trials loaded